Antimicrobial agents and chemotherapy

• 

  Año 2008, Vol. 52, Número 1

  • Interpretation of antibiotic concentration ratios measured in epithelial lining fluid

    Sungmin Kiem, Jerome J. Schentag

    págs. 24-36

    

  • Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria

    Gary J. Noel, Richard S. Strauss, Karen Amsler, Markus Heep, Rienk Pypstra, Joseph S. Solomkin

    págs. 37-44

    

  • Mutated response regulator graR is responsible for phenotypic conversion of staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance

    H. M. Neoh, L. Cui, Harumi Yuzawa, F. Takeuchi, Miki Matsuo, K. Hiramatsu

    págs. 45-53

    

  • Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro

    Emanuela Balestrieri, Claudia Matteucci, Arianna Ascolani, Anna Piperno, Roberto Romeo, Ugo Chiacchio, Giovanni Romeo, Antonio Mastino, Beatrice Macchi

    págs. 54-64

    

  • In Vitro and In Vivo Antibacterial Activities of DC-159a, a New Fluoroquinolone

    Kazuki Hoshino, Kazue Inoue, Yoichi Murakami, Yuichi Kurosaka, Kenji Namba, Yoshinori Kashimoto, Saori Uoyama, Ryo Okumura, Saito Higuchi, T. Otani

    págs. 65-76

    

  • In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci

    Catherine Clark, K. Smith, L. M. Ednie, T. Bogdanovich, Bonifacio Dewasse, Pamela McGhee, P. C. Appelbaum

    págs. 77-84

    

  • Comparative Analysis of the Bactericidal Activities of Amphibian Peptide Analogues against Multidrug-Resistant Nosocomial Bacterial Strains

    Maria Luisa Mangoni, G. Maisetta, Mariagrazia Di Luca, Ludovica Marcellini Hercolani Gaddi, Semih Esin, Walter Florio, Franca Lisa Brancatisano, Donatella Barra, Mario Campa, Giovanna Batoni

    págs. 85-91

    

  • Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

    Yi Zhou, Doug J. Bartels, Brian L. Hanzelka, U. Muh, Yunyi Wei, Hui-May Chu, Ann M. Tigges, Debra L. Brennan, B. Govinda Rao, Lora Swenson, Ann D. Kwong, Chao Lin

    págs. 110-120

    

  • Betulinic Acid Derivatives That Target gp120 and Inhibit Multiple Genetic Subtypes of Human Immunodeficiency Virus Type 1

    Weihong Lai, Li Huang, Phong Ho, Zhijun Li, David Montefiori, C. H. Chen

    págs. 128-136

    

  • Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 reverse transcriptase facilitates dual resistance to zidovudine and lamivudine

    Shannon Zelina, Chih-Wei Sheen, Jessica Radzio, John W. Mellors, Nicolas Sluis-Cremer

    págs. 157-163

    

  • Fusarium and Candida albicans Biofilms on Soft Contact Lenses: Model Development, Influence of Lens Type, and Susceptibility to Lens Care Solutions

    Y. Imamura, Jyotsna Chandra, Pranab K. Mukherjee, Ali Abdul Lattif, Loretta B. Szczotka-Flynn, Eric Pearlman, Jonathan H. Lass, Kerry O'Donnell, M. Ghannoum

    págs. 171-182

    

  • Outcome of vancomycin treatment in patients with methicillin-susceptible staphylococcus aureus bacteremia

    Sung-Han Kim, Kye-Hyung Kim, H. B. Kim, N. J. Kim, Eui-Chong Kim, Myoung-don Oh, Kang-Won Choe

    págs. 192-197

    

  • Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections

    J. A. Passarell, A. K. Meagher, K. Liolios, B.B. Cirincione, S. A. Van Wart, T. Babinchak, E. J. Ellis-Grosse, P. G. Ambrose

    págs. 204-210

    

  • Novel Trypanocidal Analogs of 5'-(Methylthio)-Adenosine

    Janice R. Sufrin, Arthur J. Spiess, Canio J. Jr. Marasco, Donna Rattendi, Cyrus J. Bacchi

    págs. 211-219

    

  • Comparative Evaluation of the Inhibitory Activities of a Series of Pyrimidinedione Congeners That Inhibit Human Immunodeficiency Virus Types 1 and 2

    Robert W., Jr. Buckheit, Tracy L. Hartman, Karen M. Watson, Sun-Gan Chung, Eui-Hwan Cho

    págs. 225-236

    

  • Pharmacokinetics and efficacy of piperaquine and chloroquine in melanesian children with uncomplicated malaria

    H. A. Karunajeewa, K. F. Ilett, Ivo Mueller, Peter Siba, Irwin Law, Madhu Page-Sharp, Enmoore Lin, Jovitha Lammey, Kevin T. Batty, Timothy M.E. Davis

    págs. 237-243

    

  • Mosaic tetracycline resistance genes and their flanking regions in bifidobacterium thermophilum and lactobacillus johnsonii

    Angela H. A. M. van Hoek, Sigrid Mayrhofer, Konrad J. Domig, Ana Belén Flórez García, M. S. Ammor, Baltasar Mayo Pérez, Henk J. M. Aarts

    págs. 248-252

    

  • Failures in clinical treatment of staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding

    Tiffanny Jones, M. R. Yeaman, G. Sakoulas, Soo-Jin Yang, Richard A. Proctor, Hans-Georg Sahl, Jacques Schrenzel, Y. Q. Xiong, A. S. Bayer

    págs. 269-278

    

  • Identification and Evaluation of a Highly Effective Fusion Inhibitor for Human Metapneumovirus

    Céline Deffrasnes, M. E. Hamelin, G. A. Prince, G. Boivin

    págs. 279-287

    

  • Hepatitis B Virus e Antigen Loss during Adefovir Dipivoxil Therapy Is Associated with Enhanced Virus-Specific CD4+ T-Cell Reactivity

    Helen Cooksley, Shilpa Chokshi, Yafit Maayan, Heiner Wedemeyer, Pietro Andreone, Richard Gilson, Thomas Warnes, Simona Paganin, Fabien Zoulim, Frederick Frederick, Avidan U. Neumann, Carol L. Brosgart, Nikolai V. Naoumov

    págs. 312-320

    

  • Human Immunodeficiency Virus Types 1 and 2 Exhibit Comparable Sensitivities to Zidovudine and Other Nucleoside Analog Inhibitors In Vitro

    Robert A. Smith, Geoffrey S. Gottlieb, D. J. Anderson, Crystal L. Pyrak, Bradley D. Preston

    págs. 329-332

    

  • Salmonella genomic Island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in proteus mirabilis clinical and food isolates from China

    D. A. Boyd, Xiaolu Shi, Qing-hua Hu, Lai King Ng, B. Doublet, A. Cloeckaert, M. R. Mulvey

    págs. 340-344

    

  • No genetic bottleneck in plasmodium falciparum wild-Type pfcrt alleles reemerging in Hainan Island, China, following high-level chloroquine resistance

    N. Chen, Qi Gao, Shanqing Wang, Guangze Wang, M. L. Gatton, Q. Cheng

    págs. 345-347

    

  • Increased macrolide resistance of mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia

    M. Morozumi, Satoshi Iwata, K. Hasegawa, N. Chiba, Reiko Takayanagi, Keita Matsubara, Eiichi Nakayama, K. Sunakawa, K. Ubukata, Acute Respiratory Diseases Study Group

    págs. 348-350

    

  • Antimicrobial resistance genes associated with salmonella enterica serovar newport isolates from food animals

    Aaron M. Lynne, Bobbie S. Rhodes-Clark, Kimberly Bliven, Shaohua Zhao, Steven L. Foley

    págs. 353-356

    

  • Madurahydroxylactone Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and RNase H

    Christophe Marchand, John A. Beutler, Antony Wamiru, Scott Budihas, Ute Möllmann, Lothar Heinisch, John W. Mellors, Stuart F. Le Grice, Yves Pommier

    págs. 361-364

    

  • Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of streptococcus pneumoniae from 12 children treated with levofloxacin

    T. A. Davies, Eugene Leibovitz, Gary J. Noel, David F. McNeeley, Karen Bush, Ron Dagan

    págs. 378-381